Natco Pharma completes transition of DASH Pharmaceuticals into Natco Pharma USAAs of Jan. 2, all products marketed by the company will transition to the Natco Pharma USA label, with no changes to the current NDC numbers. Endo files reorganization plan to emerge from bankruptcyThe plan paves the way for Endo to successfully conclude financial restructuring in the second quarter of 2024. Teva intros generic Forteo Generic Forteo is used to treat men and women with certain types of osteoporosis. Hikma intros phenylephrine HCl Injection Phenylephrine HCl Injection is indicated for increasing blood pressure in adults with hypotension resulting primarily from vasodilation in the setting of anesthesia. Amneal moves to Nasdaq The Nasdaq move will be effective on Dec. 27, 2023. Alembic rolls out generic Aczone Dapsone Gel is a sulfone indicated for the topical treatment of acne vulgaris in patients aged 9 years old and older. Long Grove partners with Sunny Pharmtech to launch cyclophosphamide for injection Cyclophosphamide for Injection is an antineoplastic chemotherapy medication that slows the growth of cancer cells. Dr. Reddy’s debuts on Dow Jones Sustainability World Index The company retains its place in the Dow Jones Sustainability Index for Emerging Markets for an eighth year in a row. Elite ships generic Adderall XR to marketing partner Prasco Prasco will market the products under Burel Pharmaceutical's label, and Elite will manufacture the products. Bio-Thera Solutions obtains FDA OK for Avastin biosimilar Avzivi is used to treat lung, colorectal and other cancers. First Previous 37 38 39 40 41 Next Last
